Trials / Sponsors / XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Industry · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Cont Spinal Cord Injury, Safety, Efficacy | Phase 2 | 2028-05-25 |
| Recruiting | Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease Parkinson Disease (PD) | Phase 1 / Phase 2 | 2025-09-22 |
| Recruiting | The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjec Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | 2025-09-15 |
| Recruiting | The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease Parkinson's Disease | Phase 1 | 2025-08-05 |
| Recruiting | Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury Spinal Cord Injury, Safety, Clinical Trials | Phase 1 | 2025-07-02 |